These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29752635)

  • 1. Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.
    Yazar T; Yazar HO; Zayimoğlu E; Çankaya S
    Neurol Sci; 2018 Aug; 39(8):1415-1421. PubMed ID: 29752635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of sarcopenia and dynapenia according to stage among Alzheimer-type dementia patients.
    Yazar T; Olgun Yazar H
    Ideggyogy Sz; 2019 May; 72(5-6):171-179. PubMed ID: 31241261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia, dynapenia, and body composition in Parkinson's disease: are they good predictors of disability?: a case-control study.
    Ozer FF; Akın S; Gultekin M; Zararsız GE
    Neurol Sci; 2020 Feb; 41(2):313-320. PubMed ID: 31583555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of sarcopenia in patients with geriatric depression diagnosis.
    Olgun Yazar H; Yazar T
    Ir J Med Sci; 2019 Aug; 188(3):931-938. PubMed ID: 30610679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease.
    Erdogan T; Bahat G
    Neurol Sci; 2019 Mar; 40(3):625. PubMed ID: 30338435
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of mental health of carers according to patient stage of idiopathic Parkinson's disease.
    Olgun Yazar H; Yazar T; Yancar Demir E; Cankaya S; Enginyurt Ö
    Ideggyogy Sz; 2018 May; 71(5-06):205-212. PubMed ID: 29889463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Sarcopenia and Dynapenia and Their Determinants in Iranian Peritoneal Dialysis Patients.
    As'habi A; Najafi I; Tabibi H; Hedayati M
    Iran J Kidney Dis; 2018 Jan; 12(1):53-60. PubMed ID: 29421778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dynapenia and decline in higher-level functional capacity in older men with diabetes.
    Ida S; Murata K; Nakadachi D; Ishihara Y; Imataka K; Uchida A; Monguchi K; Kaneko R; Fujiwara R; Takahashi H
    Geriatr Gerontol Int; 2018 Sep; 18(9):1393-1397. PubMed ID: 30094914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary data: Evaluation of serum Galectin-3 levels in patients with Idiopathic Parkinson's Disease.
    Yazar HO; Yazar T; Cihan M
    J Clin Neurosci; 2019 Dec; 70():164-168. PubMed ID: 31471077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia and dynapenia is correlated to worse quality of life perception in middle-aged and older adults with Parkinson's disease.
    da Costa Pereira JP; Queiroz Júnior JRA; Medeiros LC; Araújo Bezerra GK; Porto IVP; Cabral PC; Luz MCLD; Pinho CPS; Romero RA
    Nutr Neurosci; 2024 Apr; 27(4):310-318. PubMed ID: 36932322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
    Mori H; Kuroda A; Yoshida S; Yasuda T; Umayahara Y; Shimizu S; Ryomoto K; Yoshiuchi K; Yamamoto T; Matsuoka TA; Shimomura I; Matsuhisa M
    J Diabetes Investig; 2021 Jun; 12(6):1050-1059. PubMed ID: 33063949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and Dynapenia in Patients With Parkinsonism.
    Barichella M; Pinelli G; Iorio L; Cassani E; Valentino A; Pusani C; Ferri V; Bolliri C; Pasqua M; Pezzoli G; Frazzitta G; Cereda E
    J Am Med Dir Assoc; 2016 Jul; 17(7):640-6. PubMed ID: 27143236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalance of sarcopenia according to decade.
    Yazar T; Olgun Yazar H
    Clin Nutr ESPEN; 2019 Feb; 29():137-141. PubMed ID: 30661677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes.
    Mori H; Kuroda A; Ishizu M; Ohishi M; Takashi Y; Otsuka Y; Taniguchi S; Tamaki M; Kurahashi K; Yoshida S; Endo I; Aihara KI; Funaki M; Akehi Y; Matsuhisa M
    J Diabetes Investig; 2019 Sep; 10(5):1332-1340. PubMed ID: 30677242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinant factors of sarcopenia in individuals with Parkinson's disease.
    da Luz MCL; Bezerra GKA; Asano AGC; Chaves de Lemos MDC; Cabral PC
    Neurol Sci; 2021 Mar; 42(3):979-985. PubMed ID: 32683568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia among hospitalized patients - A cross-sectional study.
    Sousa AS; Guerra RS; Fonseca I; Pichel F; Amaral TF
    Clin Nutr; 2015 Dec; 34(6):1239-44. PubMed ID: 25577017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study.
    Lee WJ; Liu LK; Peng LN; Lin MH; Chen LK;
    J Am Med Dir Assoc; 2013 Jul; 14(7):528.e1-7. PubMed ID: 23664768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between dynapenia and cognitive decline in community-dwelling older Japanese adults: The IRIDE Cohort Study.
    Hatanaka S; Sasai H; Shida T; Osuka Y; Kojima N; Ohta T; Abe T; Yamashita M; Obuchi SP; Ishizaki T; Fujiwara Y; Awata S; Toba K;
    Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():123-129. PubMed ID: 38116709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
    Bahat G; Tufan A; Tufan F; Kilic C; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
    Clin Nutr; 2016 Dec; 35(6):1557-1563. PubMed ID: 26922142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional status and dynapenia in people living with Parkinson's disease: a cross-sectional study.
    de Medeiros LC; da Luz MCL; da Costa Pereira JP; Bezerra GKA; Cabral PC
    Neurol Sci; 2022 Apr; 43(4):2509-2517. PubMed ID: 34686931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.